Scholarly Index
Hiroyuki Suzuki
Tohoku University; 14,776 total citations; 516 total publications; best world rank #74
Tohoku University
14,776Total citations
516Total publications
62H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lymphatic System and Diseases | Lifetime | 634 | JP 51 | 89.75 |
| TGF-β signaling in diseases | Lifetime | 950 | JP 111 | 89.47 |
| Glycosylation and Glycoproteins Research | 2021-2025 | 166 | JP 10 | 93.38 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 514 | JP 13 | 92.87 |
| Proteoglycans and glycosaminoglycans research | 2021-2025 | 74 | JP 6 | 89.64 |
| Cancer Cells and Metastasis | 2021-2025 | 617 | JP 20 | 87.27 |
| HER2/EGFR in Cancer Research | 2021-2025 | 636 | JP 38 | 89.86 |
| Lymphatic System and Diseases | 2021-2025 | 168 | JP 9 | 87.32 |
| Chemokine receptors and signaling | 2021-2025 | 148 | JP 2 | 80.30 |
| Cell Adhesion Molecules Research | 2021-2025 | 510 | JP 34 | 76.70 |
| Galectins and Cancer Biology | 2021-2025 | 421 | JP 24 | 76.53 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 297 | JP 17 | 75.54 |
| Veterinary Oncology Research | 2021-2025 | 952 | JP 82 | 62.03 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 573 | JP 45 | 38.89 |
| Lymphatic Disorders and Treatments | 2021-2025 | 276 | JP 21 | 28.32 |